Egalet
Wayne
About Egalet
Egalet is a specialty pharmaceutical company that develops pain management products. The company is developing a pipeline of abuse-resistant opioids that are nearing pivotal testing. Egalet has pioneered one of the world’s first erosion-based delivery technologies to enable the controlled release of drugs through gradual erosion of a tablet and has optimized the abuse deterrent properties that can be applied to a broad range of opioids and non-opioids.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Estimated revenue: $50K – $100K
- Total funding: $115.2M
- Funding stage: IPO
- Last round: Post-IPO Debt (Sep 2016)
- Ticker: otcpink:ZCOR
- Website: egalet.com
- Phone: 45-44-47-80-80
Industries & Categories
Biopharma, Biotechnology, Health Care
Social Profiles
Canonical: https://fsome.com/organization/egalet-2220683 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.